Esophageal Diseases  >>  Onivyde (nanoliposomal irinotecan)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Onivyde (nanoliposomal irinotecan) / Servier, Ipsen
NCT00813072 / 2006-006452-35: Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma

Completed
2
135
Europe, RoW
PEP02, liposome irinotecan, irinotecan, Campto, docetaxel, Taxetere
PharmaEngine
Stomach Neoplasms, Esophageal Neoplasms
07/10
12/10

Download Options